-
1.
公开(公告)号:US08828401B2
公开(公告)日:2014-09-09
申请号:US13670612
申请日:2012-11-07
Applicant: Pfizer Inc.
Inventor: Matthew David Doroski , Andreas Maderna , Christopher John O'Donnell , Chakrapani Subramanyam , Beth Vetelino , Russell George Dushin , Pavel Strop , Edmund Idris Graziani
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
Abstract translation: 本发明涉及细胞毒性五肽,其抗体药物偶联物及其用于治疗癌症的方法。
-
公开(公告)号:US09249186B2
公开(公告)日:2016-02-02
申请号:US14793942
申请日:2015-07-08
Applicant: PFIZER INC.
Inventor: Matthew David Doroski , Andreas Maderna , Christopher John O'Donnell , Chakrapani Subramanyam , Beth Vetelino , Russell George Dushin , Pavel Strop , Edmund Idris Graziani
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
-
3.
公开(公告)号:US09138486B2
公开(公告)日:2015-09-22
申请号:US14322262
申请日:2014-07-02
Applicant: PFIZER INC.
Inventor: Matthew David Doroski , Andreas Maderna , Christopher John O'Donnell , Chakrapani Subramanyam , Beth Vetelino , Russell George Dushin , Pavel Strop , Edmund Idris Graziani
CPC classification number: C07K7/06 , A61K38/06 , A61K38/07 , A61K38/08 , A61K47/6803 , A61K47/6811 , A61K47/6851 , A61K47/6855 , A61K47/6863 , A61K47/6889 , C07K5/0205 , C07K5/0808 , C07K7/02 , C07K16/00 , C07K2319/30
Abstract: The present invention is directed to cytotoxic pentapeptides, to antibody drug conjugates thereof, and to methods for using the same to treat cancer.
Abstract translation: 本发明涉及细胞毒性五肽,其抗体药物偶联物及其用于治疗癌症的方法。
-
公开(公告)号:US10689458B2
公开(公告)日:2020-06-23
申请号:US15356750
申请日:2016-11-21
Applicant: Pfizer Inc.
Inventor: Dangshe Ma , Frank Loganzo, Jr. , Kimberly Ann Marquette , Edmund Idris Graziani , Puja Sapra , Pavel Strop
Abstract: The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
-
-
-